NCT06539715CompletedPhase 4
Comparison of Visual Field Assessments Between Three Perimeters
Source: ClinicalTrials.gov · Last updated 30 Apr 2026
Brief summary (registry, in English)
A single center, prospective, randomized, comparative study of visual field assessments between the TEMPO, VisuALL, and HFA perimeters. Subjects will be assessed at 1 visit. Clinical evaluations will include MD, PSD, FT, VFI, OCT, and a questionnaire.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 54 (actual)
- First submitted
- 25 Jul 2024
- Start date
- 18 Nov 2024
- Primary completion date
- 12 Mar 2025
- Lead sponsor
- Gainesville Eye Associates
- Diseases
- Glaucoma
- NCT number
- NCT06539715
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 54
- From 18 Nov 2024 to the primary completion date, 12 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Any ocular or systemic conditions, that could affect VF test results, such as age-related macular degeneration, peripheral retinal disease, or severe glaucoma.
- The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial.
Other
- Unable to tolerate ophthalmic imaging
Who the study is looking for
- Adult patients with best-corrected visual outcomes of 20/30 or better.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| North Georgia Eye Associates Coordinator of this site? Confirm its status | Gainesville | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.